SEC Comment Letter for KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — May 28, 2009

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: May 28, 2009 · CIK: 0001075880 · Accession: 0000000000-09-028340

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-29962

Date

May 28, 2009

Author

Jeffrey P. Riedler

Form

UPLOAD

Company

KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 May 28, 2009 Mr. Philip A. Johnston Chairman Novogen Limited 140 Wicks Road North Ryde, New South Wales 2113, AUSTRALIA Re: Novogen Limited Form 20-F for the Year Ended June 30, 2008 Filed December 5, 2008 File No. 000-29962

Dear Mr. Johnston: We have completed our review of your annual report on Form 20-F and have no further comments at this time. Sincerely, J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

cc: Martina A. Brosnahan, Esq. (via facsimile to 212.309.6001)

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                  May 28, 2009   Mr. Philip A. Johnston Chairman Novogen Limited 140 Wicks Road North Ryde, New South Wales 2113, AUSTRALIA
Re: Novogen Limited
 Form 20-F for the Year Ended June 30, 2008  Filed December 5, 2008  File No. 000-29962

Dear Mr. Johnston:
  We have completed our review of your  annual report on Form 20-F and have no
further comments at this time.
Sincerely,
           J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

 cc: Martina A. Brosnahan, Esq. (via facsimile to 212.309.6001)

SecProbe.io